InsidersTradesSigma
China Pharma Holdings, INC. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the China Pharma Holdings, INC. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, China Pharma Holdings, INC. has recorded 3 reports. Market capitalisation: €18.8m. The latest transaction was disclosed on 19 October 2023 (Attribution). Among the most active insiders: Li Zhilin. The full history is free.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
43Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,746 of 26,179 companies
16.4
score / 100
Value27
Quality6
FCF yld0.0%
Earn yld-11%
EV/EBITDA·
ROE-21%
Gross mgn-3.2%
Net mgn-77%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 October 2023
Declarations3 total
3 of 3 declarations
